TY - JOUR T1 - TARA study: a new perspective on tapering drugs in RA JF - Annals of the Rheumatic Diseases JO - Ann Rheum Dis DO - 10.1136/annrheumdis-2019-215594 SP - annrheumdis-2019-215594 AU - Debashish Mishra AU - Arghya Chattopadhyay AU - Sanjay Jain AU - Varun Dhir Y1 - 2019/05/09 UR - http://ard.bmj.com/content/early/2019/05/08/annrheumdis-2019-215594.abstract N2 - We read with great interest the article on ‘Gradual tapering TNF inhibitors vs conventional synthetic DMARDs after achieving controlled disease in patients with rheumatoid arthritis: first-year results of the randomised controlled TARA study’1by van Mulligen et al. This was the first head-to-head comparison between two tapering strategies—biological versus conventional in rheumatoid arthritis. The final results favour tapering tumour necrosis factor inhibitors (TNFis) before conventional synthetic disease-modifying antirheumatic drugs (csDMARDs). However, certain points need clarifications.First, many patients in the … ER -